GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kenvue KVUE · USD

Consumer Staples · Personal Care Products · US listing · 🇺🇸 United States

S&P 500

Compare

19.31

-1.28%

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Kenvue — daily KVUE Delayed
Market value
$37.08bn
Last close × shares
Volume
66.6m
Shares, 30 Oct 2026
Price to earnings
25.2
Dividend yield
4.31%

About Kenvue

From its filings with the US Securities and Exchange Commission

SEC filings

Kenvue is based in Summit, New Jersey and is incorporated in Delaware. Its shares trade on NYSE under the ticker KVUE. It is a member of the S&P 500. The SEC classifies its business as perfumes, cosmetics & other toilet preparations. In the fiscal year to 28 December 2025, it reported revenue of $15.12bn and net income of $1.47bn. At that date it held total assets of $27.08bn and shareholders' equity of $10.77bn.

In its own words

At Kenvue, our purpose is to realize the extraordinary power of everyday care. As a global leader at the intersection of healthcare and consumer goods, we are the world’s largest pure-play consumer health company by revenue with $15.1 billion in Net sales in the fiscal year 2025. By combining the power of science with meaningful consumer insights and our digital strategy, we empower consumers to live healthier lives every day. Built on more than a century of heritage and trusted by generations, our differentiated portfolio of iconic brands—including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, Nicorette®, Tylenol®, and Zyrtec®—is backed by science and recommended by healthcare professionals, which further reinforces our consumers’ connections to our brands.

Our portfolio includes Self Care, Skin Health and Beauty, and Essential Health products, allowing us to connect with consumers across North America, Asia Pacific (“APAC”), Europe, Middle East, and Africa (“EMEA”), and Latin America (“LATAM”) in their daily rituals and the moments that matter most. Our products are marketed across more than 165 countries worldwide.

Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗

More about Kenvue →

Latest on Kenvue

Our reporting

Next results

11 Nov 2026

Due on 11 Nov 2026. Analysts expect earnings of 0.30 a share.

Other Consumer Staples listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Kenvue's ticker?

Kenvue trades as KVUE on its US listing, under ISIN US49177J1025.

What was Kenvue's last closing price?

19.31 on 30 Oct 2026. The figure is in USD and is never converted.

When does Kenvue next report results?

Results are expected on 11 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.